Countries like Germany, France, and Canada temporarily stopped using AstraZeneca's vaccine after reports of rare blood clots. There is no evidence to restrict the use of the shot, Europe's regulator says.

Countries like Germany, France, and Canada temporarily stopped using AstraZeneca's vaccine after reports of rare blood clots. There is no evidence to restrict the use of the shot, Europe's regulator says.

Business Insider

Published

The European Medicines Agency will conclude its investigation into possible rare side effects associated with AstraZeneca's COVID-19 vaccine next week.

Full Article